Serotonin is probably the main but not the sole determinant of cardiac involvement in NETs, and other mediators detected in the endocardial plaques of CHD patients, such as activin A (a member of the TGF-β family), were found to play a role. This evidence concerns the gene TGFB1 and coronary artery disorder.